ArticleFrontiers in pharmacology2022

c-Myc-PD-L1 Axis Sustained Gemcitabine-Resistance in Pancreatic Cancer.

Jingjing Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.